Crohn’s Disease and Ulcerative Colitis stem cell therapy
6. Crohn’s Disease Intravenous infusion of autologous MSCs has demonstrated significant efficacy in managing Crohn’s disease by reducing abdominal pain, improving bowel function, y reducir la inflamación. MSCs modulate immune responses by suppressing pro-inflammatory cytokines, enhancing regulatory T-cell activity, y promover la curación de la mucosa. The paracrine signaling of MSCs stimulates epithelial regeneration Leer más





